Tissue transglutaminase and the progression of human renal scarring

Journal of the American Society of Nephrology

Volumn 14, Issue 8, 2003, Pages 2052-2062

  Johnson, Timothy S ^a,d   El Koraie, Ahmed F ^a   Skill, N James ^a,c   Baddour, Nahed M ^b   El Nahas, A Meguid ^a   Njloma, Melvin ^a   Adam, Ahmed G ^b   Griffin, Martin ^c  

^a Sheffield Kidney Institute   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 (GAMMA GLUTAMYL)LYSINE; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS LINKING; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY SCAR; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MESANGIUM CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0041342003     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000079614.63463.DD     Document Type: Article

References (41)

1. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000
2. Fogo AB: Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int Suppl 75: S15-S21, 2000
3. Basile DP: The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions. Curr Opin Nephrol Hypertens 8: 21-30, 1999
4. Douthwaite JA, Johnson TS, Haylor JL, Watson P, El Nahas AM: Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol 10: 2109-2119, 1999
5. Lorand L, Conrad SM: Transglutaminases. Mol Cell Biochem 58: 9-35, 1984
6. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 272: G281-G288, 1997
7. Kleman JP, Aeschlimann D, Paulsson M, van der Rest M: Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34: 13768-13775, 1995
8. Johnson TS, Skill NJ, El Nahas AM, Oldroyd SD, Thomas GL, Douthwaite JA, Haylor JL, Griffin M: Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 10: 2146-2157, 1999
9. Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, Meguid El Nahas A: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99: 2950-2960, 1997
10. 2+ and nucleotides. Biochem J 313: 803-808, 1996
11. Aeschlimann D, Paulsson M: Cross-linking of laminin-nidogen complexes by tissue transglutaminase: A novel mechanism for basement membrane stabilization. J Biol Chem 266: 15308-15317, 1991
12. Johnson TS, Scholfield CI, Parry J, Griffin M: Induction of tissue transglutaminase by dexamethasone: Its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem J 331: 105-112, 1998
13. Verderio E, Nicholas B, Gross S, Griffin M: Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: Effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 239: 119-138, 1998
14. Knight RL, Hand D, Piacentini M, Griffin M: Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver: Its relationship to apoptosis. Eur J Cell Biol 60: 210-216, 1993
15. Knight CR, Rees RC, Griffin M: Apoptosis: A potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta 1096: 312-318, 1991
16. Fesus L, Thomazy V, Falus A: Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224: 104-108, 1987
17. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM: Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 13: 2216-2226, 1998
18. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136: 1151-1163, 1997
19. Verderio E, Gaudry C, Gross S, Smith C, Downes S, Griffin M: Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem 47: 1417-1432, 1999
20. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM: Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J Biol Chem 265: 11098-11104, 1990
21. Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, Griffin M: Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem 274: 30707-30714, 1999
22. Birckbichler PJ, Upchurch HF, Patterson MK Jr, Conway E: A monoclonal antibody to cellular transglutaminase. Hybridoma 4: 179-186, 1985
23. Roch AM, Noel P, el Alaoui S, Charlot C, Quash G: Differential expression of isopeptide bonds N epsilon (gamma-glutamyl) lysine in benign and malignant human breast lesions: An immunohistochemical study. Int J Cancer 48: 215-220, 1991
24. el Alaoui S, Legastelois S, Roch AM, Chantepie J, Quash G: Transglutaminase activity and N epsilon (gamma glutamyl) lysine isopeptide levels during cell growth: An enzymic and immunological study. Int J Cancer 48: 221-226, 1991
25. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Skill NJ, Haylor JL, El Nahas AM: Expression of apoptosis-related genes and proteins in experimental chronic renal scarring. J Am Soc Nephrol 12: 275-288, 2001
26. Skill NJ, Griffin M, El Nahas AM, Sanai T, Haylor JL, Fisher M, Jamie MF, Mould NN, Johnson TS: Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: Pathologic implications. Lab Invest 81: 705-716, 2001
27. Kreisberg JI, Venkatachalam M, Troyer D: Contractile properties of cultured glomerular mesangial cells. Am J Physiol 249: F457-F463, 1985
28. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cell: A glomerular "myofibroblast"? J Am Soc Nephrol 2: S190, S197, 1992
29. Bowness JM, Venditti M, Tarr AH, Taylor JR: Increase in epsilon(gamma-glutamyl)lysine crosslinks in atherosclerotic aortas. Atherosclerosis 111: 247-253, 1994
30. Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, Huang TP, Atkins RC, Lan HY: Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 14: 2860-2872, 1999
31. Bowness JM, Folk JE, Timpl R: Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem 262: 1022-1024, 1987
32. Martinez J, Chalupowicz DG, Roush RK, Sheth A, Barsigian C: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 33: 2538-2545, 1994
33. Goumenos DS, Tsamandas AC, Oldroyd S, Sotsiou F, Tsakas S, Petropoulou C, Bonikos D, El Nahas AM, Vlachojannis JG: Transforming growth factor-beta(1) and myofibroblasts: A potential pathway towards renal scarring in human glomerular disease. Nephron 87: 240-248, 2001
34. Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El Nahas AM: Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 13: 1652-1661, 1998
35. Goumenos DS, Brown CB, Shortland J, el Nahas AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 9: 1418-1425, 1994
36. Seiving B, Ohlsson K, Linder C, Stenberg P: Transglutaminase differentiation during maturation of human blood monocytes to macrophages. Eur J Haematol 46: 263-271, 1991
37. Gosiewska A, Yi CF, Blanc-Brude O, Geesin JC: Characterization of a macrophage-based system for studying the activation of latent TGF-beta. Methods Cell Sci 21: 47-56, 1999
38. Abe S, Yamashita K, Kohno H, Ohkubo Y: Involvement of transglutaminase in the receptor-mediated endocytosis of mouse peritoneal macrophages. Biol Pharm Bull 23: 1511-1513, 2000
39. Akimov SS, Belkin AM: Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98: 1567-1576, 2001
40. Greenberg C, Birckbichler P, Rice R: Transglutaminases: Multifunctional enzymes that stabilise tissues. FEBS Letts 5: 3071-3077, 1991
41. Kojima S, Nara K, Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 121: 439-448, 1993